FDA Approves Second Alzheimer’s Drug, Despite Safety Concerns

FRIDAY, Jan. 6, 2023 -- The U.S. Food and Drug Administration on Friday approved a second Alzheimer's drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients.
However, the FDA pointed to the drug's benefits,...